| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/04/2013 | WO2013049300A1 Method of treating mucoepidermoid carcinoma |
| 04/04/2013 | WO2013049293A1 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders |
| 04/04/2013 | WO2013049289A1 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders |
| 04/04/2013 | WO2013049287A1 Crystalline hydrochloride salt of (1- (4 -fluorophenyl) - 1h - indol - 5 - yl) - (3- (4- (thiazole - 2 - carbonyl) piperazin- 1 - yl) az etidin- 1 -yl) methanone and its use in the treatment of pain and metabolic disorders |
| 04/04/2013 | WO2013049263A1 Substituted bicyclic heteroaryl compounds |
| 04/04/2013 | WO2013049255A1 Substitued 5-(prop-1-yn-1-yl)picolinamide analogs as allosteric modulators of mglur5 receptors |
| 04/04/2013 | WO2013049220A1 Novel vaccination strategies or therapeutic treatment for influenza virus |
| 04/04/2013 | WO2013049174A1 Substituted octahydropyrrolo[1,2-a]pyrazine sulfonamides as calcium channel blockers |
| 04/04/2013 | WO2013049164A1 SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS |
| 04/04/2013 | WO2013049119A1 Selective nr2b antagonists |
| 04/04/2013 | WO2013049104A1 Pyridinedione carboxamide inhibitors of endothelial lipase |
| 04/04/2013 | WO2013049096A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors |
| 04/04/2013 | WO2013049093A1 Combination therapy for chemoresistant cancers |
| 04/04/2013 | WO2013049033A1 Bladder catheter irrigation method and composition |
| 04/04/2013 | WO2013049021A1 Process for the preparation of sulfamide derivatives |
| 04/04/2013 | WO2013048995A1 Compounds for the treatment of hepatitis c |
| 04/04/2013 | WO2013048982A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors |
| 04/04/2013 | WO2013048949A2 Selective nr2b antagonists |
| 04/04/2013 | WO2013048942A1 Quinolinone carboxamide inhibitors of endothelial lipase |
| 04/04/2013 | WO2013048930A1 Pyridinedione carboxamide inhibitors of endothelial lipase |
| 04/04/2013 | WO2013048928A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors |
| 04/04/2013 | WO2013048787A1 Novel hemostatic compositions and dressings for bleeding |
| 04/04/2013 | WO2013048773A2 In-band peripheral authentication |
| 04/04/2013 | WO2013048734A1 Treatment and prevention of cardiovascular disease with cell derived lipid vesicles, microvesicles and exosomes |
| 04/04/2013 | WO2013048610A1 Contraceptive compositions and methods of contraception |
| 04/04/2013 | WO2013048584A2 Prodrugs for treating microbial infections |
| 04/04/2013 | WO2013048558A2 Methods of therapeutic monitoring of nitrogen scavenging drugs |
| 04/04/2013 | WO2013048452A2 Small-molecule tnf modulator to reduce the side effects of chemotherapy and radiotherapy |
| 04/04/2013 | WO2013048345A1 Methods and pharmaceutical compositions for treating cancer |
| 04/04/2013 | WO2013048334A1 Small molecules for extending the well being of cells and methods of use thereof |
| 04/04/2013 | WO2013048164A1 NOVEL COMPOUNDS AS HIF-1αINHIBITORS AND MANUFACTURING PROCESS THEREOF |
| 04/04/2013 | WO2013047958A1 Composition for inhibiting liver function deterioration, containing citrus peel extract or narirutin as active ingredient, and method for extracting narirutin from citrus peel |
| 04/04/2013 | WO2013047941A1 Method for decreasing radioresistance and growth, metastasis and infiltration of cancer cells through regulating expression or activity of tm4sf4 in non-small cell lung cancer |
| 04/04/2013 | WO2013047923A1 Nanoemulsion containing a polyaspartic acid derivative and personal care composition containing same |
| 04/04/2013 | WO2013047889A1 Pharmaceutical composition for treating autoimmune diseases |
| 04/04/2013 | WO2013047869A1 Pharmaceutical composition containing loxoprofen or salt thereof |
| 04/04/2013 | WO2013047844A1 Ngf aptamer and application thereof |
| 04/04/2013 | WO2013047813A1 1,2,4-triazine-6-carboxamide derivative |
| 04/04/2013 | WO2013047758A1 Crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate, crystal of 5-hydroxy-1h-imidazole-4-carboxamide 3/4 hydrate, and method for producing same |
| 04/04/2013 | WO2013047725A1 Drug for the treatment of allergic rhinitis comprising pgd2 antagonist and histamine antagonist |
| 04/04/2013 | WO2013047719A1 2-(pyridine-2-yl)pyrimidine-4-amine compound and salt thereof |
| 04/04/2013 | WO2013047701A1 Phenyl derivative |
| 04/04/2013 | WO2013047568A1 Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide |
| 04/04/2013 | WO2013047567A1 Corneal epithelial cell death inhibitor containing flavin adenine dinucleotide or salt thereof as active ingredient |
| 04/04/2013 | WO2013047530A1 Anti-fungal agent |
| 04/04/2013 | WO2013047410A1 Long-acting adhesive skin patch for treating alzheimer's disease, and method for producing same |
| 04/04/2013 | WO2013047373A1 Aqueous formulation containing chlorite |
| 04/04/2013 | WO2013047144A1 Cyclic amine compound and pest control agent |
| 04/04/2013 | WO2013047055A1 Heat shock protein expression inducer |
| 04/04/2013 | WO2013046335A1 Non-aqueous patch |
| 04/04/2013 | WO2013046223A1 An improved process for the preparation of bendamustine hydrochloride |
| 04/04/2013 | WO2013046219A1 Pharmaceutical composition comprising lecithin and process for preparing thereof |
| 04/04/2013 | WO2013046211A1 Processes for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl) phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophene-carboxamide and intermediates thereof |
| 04/04/2013 | WO2013046161A1 Topical pharmaceutical compositions comprising acyclovir |
| 04/04/2013 | WO2013046136A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh |
| 04/04/2013 | WO2013046133A1 Pharmaceutical compositions of n-methyl-2-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indazol-6-ylsulfanyl]-benzamide |
| 04/04/2013 | WO2013046045A1 5 - benzylaminomethyl - 6 - aminopyrazolo [3, 4 -b] pyridine derivatives as cholesteryl ester -transfer protein (cetp) inhibitors useful for the treatment of atherosclerosis |
| 04/04/2013 | WO2013046041A1 Pyridinylpyrazoles for use as kinase modulators for the treatment of cancer |
| 04/04/2013 | WO2013046029A1 Macrocyclic lrrk2 kinase inhibitors |
| 04/04/2013 | WO2013045963A1 A pharmaceutical composition for the treatment of stem cells |
| 04/04/2013 | WO2013045962A1 Pharmaceutical composition for the prevention and/or treatment of muscle atrophy |
| 04/04/2013 | WO2013045955A1 Prevention and/or treatment of cancer and/or cancer metastasis |
| 04/04/2013 | WO2013045951A1 Hydrogen sulfide releasing compounds and their use |
| 04/04/2013 | WO2013045934A2 Compositions comprising agents that inhibit neuropilin and tolloid like 2 |
| 04/04/2013 | WO2013045891A1 A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (cbdv) and cannabidiol (cbd) |
| 04/04/2013 | WO2013045826A1 Compositions containing spermine together with cadaverine, putrescine and/or spermidine |
| 04/04/2013 | WO2013045736A1 Heterocyclic gsk-3 allosteric modulators |
| 04/04/2013 | WO2013045734A1 Compounds having antileishmanial activity |
| 04/04/2013 | WO2013045730A1 Use of oxoisoaporphines in combating leishmaniasis |
| 04/04/2013 | WO2013045681A1 Improved process for the preparation of sulfamide derivatives |
| 04/04/2013 | WO2013045653A1 Macrocyclic flt3 kinase inhibitors |
| 04/04/2013 | WO2013045652A1 Inhibition of microrna-134 for the treatment of seizure-related disorders and neurologic injuries |
| 04/04/2013 | WO2013045607A1 Quinazoline linked heteroaromatic tricycle derivatives as pde10a enzyme inhibitors |
| 04/04/2013 | WO2013045566A1 N-acetylcysteine effervescent tablet and its therapeutical applications |
| 04/04/2013 | WO2013045538A1 Pharmaceutical preparation for treating nadh-caused diseases |
| 04/04/2013 | WO2013045519A1 Derivatives of 6-substituted triazolopyridazines as rev-erb agonists |
| 04/04/2013 | WO2013045505A1 Biomarkers for raas combination therapy |
| 04/04/2013 | WO2013045495A1 PYRANO[3,2-c][2]BENZOPYRAN-6(2H)-ONE DERIVATIVES AND USES THEREOF |
| 04/04/2013 | WO2013045491A1 N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations. |
| 04/04/2013 | WO2013045479A1 N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
| 04/04/2013 | WO2013045461A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 04/04/2013 | WO2013045460A1 Alisporivr for treatment of hepatis c virus infection |
| 04/04/2013 | WO2013045452A1 Substituted methanesulfonamide derivatives as vanilloid receptor ligands |
| 04/04/2013 | WO2013045451A1 Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands |
| 04/04/2013 | WO2013045447A1 Aryl or n-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands |
| 04/04/2013 | WO2013045431A1 Sulfonamide compounds and their use in the modulation retinoid - related orphan receptor |
| 04/04/2013 | WO2013045407A1 Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and use thereof for production of medicaments |
| 04/04/2013 | WO2013045400A1 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof |
| 04/04/2013 | WO2013045380A2 Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification |
| 04/04/2013 | WO2013045373A1 Oxy-cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists |
| 04/04/2013 | WO2013045330A2 Deodorant |
| 04/04/2013 | WO2013045280A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 04/04/2013 | WO2013045115A1 Cannabinoid carboxylic acids, salts of cannabinoid carboxylic acids, and the production and uses of same |
| 04/04/2013 | WO2013045068A1 Compositions comprising phytoestrogens receptor beta agonists and dietary fibres for chemopreventive treatment of sporadic adenomatous polyposis |
| 04/04/2013 | WO2013045028A1 Benzyl piperidine compounds as lysophosphatidic acid (lpa) receptor antagonist |
| 04/04/2013 | WO2013044928A1 Synthesis of hmo core structures |
| 04/04/2013 | WO2013044871A1 The use of chloroquine, chlorpromazine, derivatives thereof, or mixtures thereof in preparing medications for treating and/or preventing pulmonary infection and injury |
| 04/04/2013 | WO2013044865A1 Oxazolidinone antibiotics containing fused ring |
| 04/04/2013 | WO2013044845A1 Biaryl heterocycle substituted oxazolidinon antibacterial drug |
| 04/04/2013 | WO2013044816A1 Crystalline forms of azilsartan and preparation and uses thereof |